The STRING and KM plotter databases also predicted IRF3 as a TRAF6 binding protein, with abnormally activated IRF3 expression negatively correlating with poor prognosis of GC patients (Supplementary Fig. 2A, B). The gene discussed is TRAF6; the disease is gastric cancer.